Home › Targets › DLL-3

DLL-3 (1 companies · 2 programs)

Companies with an active program directed at DLL-3.

Legend Biotech Corp LEGN

LB2102 — Small Cell Lung Cancer Phase 1
LB2102 — Large Cell Neuroendocrine Carcinoma Phase 1